AI assistant
ANTEOTECH LTD — Board/Management Information 2017
Jul 30, 2017
64304_rns_2017-07-30_5a5d66fe-0f5c-4b40-a73d-153ec7d8baf6.pdf
Board/Management Information
Open in viewerOpens in your device viewer
31 July 2017
==> picture [315 x 91] intentionally omitted <==
Resignation of Company Secretary
Anteo Diagnostics Limited (ASX: ADO) advises the market that Mr Peter Harding-Smith has resigned as CFO and Company Secretary. The CFO duties will be performed by Glenn McInally, Principal of McVinish+McInally, on a contractual basis. Mr McInally has worked on various projects for Anteo over the past 15 months and will work closely with Mr Alan Studley, Chair of Audit and Risk committee.
The Board thanked Mr Harding-Smith for his services over the last 10 months and wish him success moving forward.
ABOUT ANTEO GROUP – Anteo Diagnostics Limited (ADO:ASX) & Subsidiaries
Anteo Group is a global nanochemistry technology and medical supply group, developing, commercialising, manufacturing and distributing products for the life sciences, clinical diagnostics and bioseparations markets, and creating new applications in the energy and medical devices sectors.
Through Anteo Technology, the Anteo Group owns a patented nanochemistry surface engineering technology which unites the strength and stability of covalent binding with the gentleness of passive binding through multi-point chelation. Through the use of its reagents binders, coatings or primers, Anteo provides materials and services for high-value commercial applications. Markets include protein binding and antibody coupling (e.g. point of care devices), primers for in-vivo medical devices and medical drug delivery, and coatings with commercial applications across a broad range of industry sectors, including life sciences, in vitro diagnostics, medical devices and energy.
Through its wholly owned subsidiary, DIAsource Immunoassays SA, Anteo Group manufactures and distributes a complete catalogue of ELISA and RIA products for clinical diagnostics via established distribution channels in 75 counties across the world, including antibodies and laboratory automation instrumentation.
For more information, please visit www.anteodx.com
==> picture [595 x 139] intentionally omitted <==